Home > M&A deals 2014 > Pamplona Capital Management acquires Alvogen, Inc.
Buyout (LBO, MBO, MBI) · Medical Products · April 2014

Pamplona Capital Management acquires Alvogen, Inc.

On April 2, 2014, Pamplona Capital Management acquired Alvogen, Inc., a medical products company in New Jersey, United States.

Deal at a glance

AnnouncedApril 2, 2014 TypeBuyout (LBO, MBO, MBI) TargetAlvogen, Inc. Buyer Pamplona Capital Management SectorMedical Products LocationNew Jersey, United States ValueNot disclosed

Target company

Alvogen, Inc.
New Jersey, United States
Alvogen is an international pharmaceuticals company focused on developing, manufacturing and distributing niche generic, over-the-counter brands and biosimilar products.
Medical Productssector
2008founded
Activestatus
View the company profile →

Buyer

Private equity firm · 35 deals on record
  • 1st transaction in medical products
  • 3rd transaction in United States
35deals, all time
2in this sector
2021latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

EET GroupSame lead buyer · Nov 2021
BFG Supply Co. LLCSame lead buyer · Nov 2021
Pelsis Ltd.Same lead buyer · Aug 2021
Seraplex, Inc.Same sector and country · Oct 2026
Aloe Care Health, Inc.Same sector and country · Apr 2026
Hologic, Inc.Same sector and country · Apr 2026

Questions about this deal

Who acquired Alvogen, Inc.?Pamplona Capital Management acquired Alvogen, Inc. on April 2, 2014.

What type of deal was it?It was a buyout (lbo, mbo, mbi) in the medical products sector in 2014.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).